The clinical trial landscape is changing. Are you ready for what’s next?
Decentralized Clinical Trials (DCTs) have evolved rapidly since their initial inception over a decade ago. While the COVID-19 pandemic accelerated their adoption, the industry is now at a crossroads. As we move beyond the initial hype, the focus has shifted toward sustainability, cost-effectiveness, and community integration.
Join RxE2 CEO Gerald Finken and renowned clinical innovation expert Craig Lipset for an insightful webinar on April 21st, 2026, at 12pm ET. Together, they will explore how community pharmacies are the key to making the DCT model work for patients and sponsors alike.
What We Will Cover
- The Evolution of the DCT: Mapping the journey from the first studies in 2011 to today’s data-driven landscape.
- The Gartner Hype Cycle: A look at the next 5–10 years of decentralized research.
- Pharmacy vs. Pharmacist: Why the human element of community pharmacy is essential for successful trial outcomes.
- Logistics & Compliance: Addressing the critical concerns of IMP disposition, reconciliation, and specialized handling requirements.
- Global Impact: How technology and changing regulations will continue to shape the growth of DCTs.
Meet the speakers!
Craig Lipset
Craig Lipset
Craig Lipset is a globally recognized leader in clinical innovation, serving as the Co-Founder and Co-Chair of the Decentralized Trials & Research Alliance (DTRA) and Managing Partner of Clinical Innovation Partners. With nearly a decade of experience as the Head of Clinical Innovation at Pfizer, Craig has been at the forefront of digital initiatives and patient engagement across the globe. Beyond his advisory work for biopharmaceutical and technology companies, he is an Adjunct Assistant Professor at Rutgers University, Vice President of Innovation for the Buffalo Initiative, and serves on the boards of the Foundation for Sarcoidosis Research and several health-tech organizations.
Gerald Finken
Gerald Finken
Gerald is a licensed pharmacist with over 40 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded CSM, a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling, Clinical Trial Research Pharmacist (CTRP®) services, and pioneered Direct-to-Patient services. In 2013, he founded Center Point Clinical Services and subsequently created the innovative Siteless CRO model. In 2020, Gerald launched RxE2 where he now serves as CEO and is bringing the practice of pharmacy to clinical trials.
Save The Date
When: April 21st, 2026 12 pm ET
Where: Online (Zoom).
How to register: https://us02web.zoom.us/meeting/register/6Btxq7vDS8WFZA6d18yKxQ#/registration
Participation is free, but slots are limited, save your spot today!
Make sure to add the event to your calendar too so you do not lose the link!
